3.3 Venous Thromboembolism, Pulmonary Embolism, and Acute Respiratory Distress
Key Takeaways
In stable nonpregnant adults in the two-tier Wells pathway, PE unlikely (≤4) supports D-dimer testing and PE likely (>4) leads directly to imaging. Treat unstable suspected PE through the emergency pathway.
An age-adjusted D-dimer threshold is age × 10 µg/L FEU for eligible patients over 50 when the local laboratory uses a validated 500 µg/L FEU assay.
High-risk PE with shock or cardiac arrest requires immediate resuscitation and an urgent reperfusion decision. Choose systemic thrombolysis or an alternative according to bleeding risk, contraindications, arrest status and available expertise.
Select anticoagulation according to haemodynamic status, renal function, comorbidities and the applicable label. Treat most PE for at least three months, then review recurrence and bleeding risk.
Berlin ARDS severity is based on oxygenation at defined positive airway pressure. The newer global definition includes some patients on high-flow oxygen. In intubated ARDS, use lung-protective ventilation and consider early prolonged proning for persistent PaO₂/FiO₂ below 150 mmHg after optimisation.
Venous Thromboembolism: Pathophysiology and Virchow's Triad
Venous Thromboembolism (VTE), encompassing Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE), is an important cause of preventable morbidity and mortality. Thrombi typically originate within the deep veins of the lower extremities (iliofemoral and popliteal veins) or pelvic venous plexuses, subsequently dislodging and migrating through the inferior vena cava and right heart chambers to occlude the pulmonary arterial bed.
Virchow's Triad and Clinical Risk Factors
The pathogenesis of venous thrombosis is governed by the three interrelated physiological components of Virchow's Triad:
- Endothelial Injury: Direct mechanical trauma, orthopaedic surgery (total hip or knee arthroplasty), pelvic fractures, intravenous cannulation, and central venous catheterisation.
- Venous Stasis: Immobility after major surgery or during acute illness, prolonged travel, heart failure and stroke with limb paresis. A previous VTE also raises the probability of a new event.
- Hypercoagulability (Thrombophilia):
- Inherited Thrombophilias:
- Factor V Leiden Mutation: A point mutation (G1691A) rendering Factor Va resistant to inactivation by Activated Protein C (APC resistance). Its frequency varies by ancestry.
- Prothrombin G20210A Gene Mutation: Leads to elevated circulating prothrombin (Factor II) levels.
- Antithrombin III Deficiency, Protein C Deficiency, and Protein S Deficiency: Natural endogenous anticoagulant deficiencies carrying a high lifetime risk of unprovoked VTE.
- Acquired prothrombotic states:
- Active Malignancy: Some tumours promote coagulation through tissue factor and other procoagulants. Migratory superficial thrombophlebitis may be a clue to an underlying malignancy.
- Exogenous Oestrogens: Combined hormonal contraception, oral oestrogen replacement and selective oestrogen receptor modulators such as tamoxifen can increase VTE risk.
- Pregnancy and Puerperium: Risk rises in pregnancy and is especially high in the first six weeks after delivery.
- Antiphospholipid Syndrome (APS): Autoimmune state characterized by persistent antiphospholipid antibodies (Lupus Anticoagulant, Anticardiolipin antibodies, anti--glycoprotein 1 antibodies) driving both venous and arterial thrombosis.
- Nephrotic Syndrome: Loss of endogenous anticoagulants and other changes in coagulation contribute to VTE risk, particularly with severe hypoalbuminaemia.
- Inherited Thrombophilias:
Acute Right Ventricular Failure Pathophysiology
The haemodynamic consequences of acute PE depend on the mechanical extent of vascular occlusion and pre-existing cardiopulmonary reserve:
- Embolic obstruction and accompanying pulmonary vasoconstriction sharply increases Pulmonary Vascular Resistance (PVR) and right ventricular afterload.
- The right ventricle (a thin-walled compliant chamber adapted to low-pressure circuits) rapidly dilates and becomes hypokinetic. Elevated RV wall tension dramatically increases RV myocardial oxygen demand while simultaneously decreasing the right coronary artery perfusion gradient during systole, precipitating acute RV ischaemia.
- Ventricular Interdependence: As the right ventricle dilates, it shifts the interventricular septum toward the left ventricle (interventricular septal flattening, producing a characteristic "D-shaped" left ventricle on short-axis echocardiography). This septal displacement impairs left ventricular diastolic filling, severely reducing left ventricular preload.
- The abrupt drop in left ventricular cardiac output causes systemic hypotension, obstructive shock, and electromechanical dissociation (pulseless electrical activity [PEA] cardiac arrest).
Clinical Presentation and Bedside Diagnostics
PE can range from an incidental finding to circulatory collapse. Suspect it in unexplained acute dyspnoea, pleuritic chest pain, haemoptysis or syncope, particularly when VTE risk factors or unilateral leg findings are present. Pleuritic pain or small-volume haemoptysis may follow peripheral pulmonary infarction. Syncope raises concern for haemodynamic compromise but does not establish where the clot lies.
Tachypnoea, sinus tachycardia and hypoxaemia are possible. In severe disease, look for cool peripheries, altered mentation, hypotension or elevated jugular venous pressure. A tender, swollen leg supports possible DVT. The PE Wells rule scores clinical signs of DVT, including leg swelling and tenderness along the deep veins. The separate DVT rule uses measured calf asymmetry.
| Bedside test | What the findings can tell you |
|---|---|
| Pulse oximetry and ABG | Hypoxaemia, hypocapnia and respiratory alkalosis can occur. Normal oxygenation and blood gases leave PE possible. |
| ECG | Sinus tachycardia is common. Anterior T-wave inversion, right bundle branch block or the pattern can reflect RV strain and may occur with other causes. |
| Chest X-ray | Often normal or nonspecific. Helps investigate alternatives such as pneumothorax or pneumonia. A pleural-based peripheral opacity (Hampton hump) may suggest infarction, and focal oligemia (Westermark sign) may suggest vascular obstruction. Neither is sufficient to diagnose PE. |
When the presentation is primarily leg swelling
For suspected lower-limb DVT from the community, use the Irish Eve protocol’s modified two-level DVT Wells rule. Its Central Figure 1 gives one point when the affected calf is more than 3 cm larger than the other calf. Use a consistent measurement point on both legs, conventionally 10 cm below the tibial tuberosity. The named NICE NG158 rule includes an exact 3 cm difference. The Irish pathway uses D-dimer to help exclude DVT in patients classified as unlikely and compression ultrasound as first-line imaging when indicated. In the likely group, proceed to ultrasound and consider interim therapeutic anticoagulation if timely imaging is unavailable and bleeding risk permits. If only the proximal veins were imaged and the first scan is negative with persistent suspicion or a positive D-dimer, follow the local pathway for repeat imaging. A painful red leg can also reflect cellulitis, superficial thrombosis, trauma or a ruptured Baker cyst.
HSE national Eve protocol · NICE NG158, table 1 · ESC DVT consensus measurement method
Pre-Test Probability Scoring: The Wells Criteria
In a haemodynamically stable adult presenting from the community, assess clinical probability. The Irish Eve protocol supports clinical judgement or a validated rule such as Wells or Geneva. The two-tier Wells PE score below is one way to guide testing. Use dedicated pathways for pregnancy and postpartum presentations. D-dimer is of limited use in hospitalised patients.
The Wells Score for PE
| Clinical Parameter | Points Assigned |
|---|---|
| Clinical signs and symptoms of DVT (minimum of leg swelling and pain with palpation) | + 3.0 |
| An alternative diagnosis is less likely than pulmonary embolism | + 3.0 |
| Heart rate > 100 beats per minute | + 1.5 |
| Immobilisation (bedbound >= 3 days) or surgery within the previous 4 weeks | + 1.5 |
| Previous objectively documented DVT or PE | + 1.5 |
| Haemoptysis | + 1.0 |
| Active malignancy (treatment ongoing, within past 6 months, or palliative) | + 1.0 |
Using the two-tier score
- PE unlikely (≤4 points): Request an appropriate high-sensitivity D-dimer. A result below the validated threshold can exclude PE in this group. A positive result requires further investigation, typically imaging.
- PE likely (>4 points): Arrange diagnostic imaging promptly. Consider therapeutic anticoagulation while testing is in progress, if the bleeding risk allows. A negative D-dimer cannot safely exclude PE at high pre-test probability.
- The three-tier version classifies low probability as <2 points, intermediate as 2–6 points and high as >6 points. Apply the diagnostic pathway that matches the version used.
D-dimer measures fibrin breakdown. Age, pregnancy, infection, cancer and recent surgery can elevate it. If the local laboratory uses a validated FEU assay with a standard threshold of 500 µg/L FEU, use age × 10 µg/L FEU in eligible patients older than 50. Check the assay and units before applying this formula.
Worked example. A stable 82-year-old with a Wells score ≤4 has an age-adjusted threshold of , equivalent to 0.82 mg/L FEU. A result of 680 µg/L FEU falls below that threshold.
Diagnostic imaging
- CT pulmonary angiography (CTPA). Usual first-line thoracic imaging in stable adults when indicated. A segmental or more proximal filling defect confirms PE in the appropriate setting. An isolated subsegmental finding may need radiology review. A high pre-test probability with negative or technically inadequate imaging warrants review and sometimes more testing before withholding treatment.
- Ventilation/perfusion scintigraphy. Consider when severe renal impairment or a serious iodinated contrast reaction makes CTPA unsuitable. A segmental perfusion defect with preserved ventilation supports PE. Interpretation depends on technique (planar versus SPECT), pattern and clinical probability. A nondiagnostic scan needs another assessment.
- Bedside echocardiography. In shock, point-of-care echo can identify RV pressure overload, assess other causes, and support a time-critical reperfusion decision if CTPA is unsafe. RV dilatation, septal flattening and the McConnell pattern can occur in other conditions. Direct visualisation of a mobile right-heart thrombus is uncommon and strongly supports thromboembolic disease. A normal echo cannot exclude PE in a stable patient.
- Leg compression ultrasound. A noncompressible proximal vein can establish VTE and justify therapeutic anticoagulation in a patient with suspected PE. A negative study cannot exclude PE. Consider whether chest imaging would alter risk stratification or management.
Pregnancy and postpartum. Use the Irish maternity pathway effective 21 October 2026. Obtain CXR and ECG for suspected PE during pregnancy. Low-dose CTPA is the usual first-line chest study in most Irish units and is favoured when the CXR is abnormal. Perfusion scanning is an option with a normal CXR. Use a validated pregnancy-adapted prediction and D-dimer pathway only where expertise is available. Ultrasound is useful with concurrent DVT symptoms. A confirmed DVT may avoid chest imaging if it would add no management information. Haemodynamic instability requires emergency echo or CTPA according to safety and feasibility.
Acute Pulmonary Embolism Risk Stratification and Management
Therapeutic management is dictated by haemodynamic stability, RV strain, and cardiac biomarker release:
1. High-Risk (Massive) Pulmonary Embolism
High-risk PE can present as cardiac arrest, obstructive shock or persistent hypotension. In a patient with a pulse, look for organ hypoperfusion and exclude other causes such as bleeding, sepsis or arrhythmia. Obtain rapid imaging according to stability. Bedside echocardiography can support an emergency decision when the patient is too unstable for CTPA. During arrest, RV dilation alone cannot establish PE.
- Support oxygenation and circulation. Avoid large fluid boluses that may worsen RV distension. Use vasopressor support as indicated and activate the local emergency PE pathway.
- Plan anticoagulation and reperfusion together. IV unfractionated heparin is commonly used in high-risk PE if suitable. Check bleeding, planned intervention and the timing of anticoagulation with the treatment team.
- If systemic fibrinolysis is appropriate in a patient with a pulse, follow the Irish product and local protocol. For example, the Irish Actilyse label uses 10 mg IV over 1–2 minutes and 90 mg infused over two hours in adults at least 65 kg, with a total-dose cap of 1.5 mg/kg below 65 kg. The label starts or resumes heparin once aPTT is less than twice the upper limit of normal.
- Check the individual contraindications. The Irish Actilyse label includes major surgery or significant trauma within the preceding three months. Seek immediate specialist assessment for surgical embolectomy or catheter-based reperfusion if available. In arrest due to suspected PE, ERC recommends fibrinolysis with continued CPR for at least 60–90 minutes after administration. The optimal agent and dose during CPR remain uncertain. Follow the arrest pathway and local protocol. When PE is confirmed, alternative reperfusion may also be available.
ESC/ERS pulmonary embolism guideline · HPRA Actilyse label · ERC special circumstances
2. Risk stratification without haemodynamic instability
Use PESI or simplified PESI, RV findings and troponin. With elevated clinical risk, intermediate-high risk requires both RV dysfunction and elevated troponin. Monitor closely for deterioration and consider rescue reperfusion if shock develops. A single abnormality in this setting supports intermediate-low risk, and an otherwise low clinical score with unexpected RV dysfunction or positive troponin also warrants reassessment. Routine systemic lysis is inappropriate in a stable intermediate-risk patient. Consider home treatment only if early complication risk is low, admission is unnecessary for other reasons, and a local pathway can provide reliable treatment, counselling and follow-up.
3. Anticoagulant selection
The Irish Eve protocol supports LMWH or an eligible DOAC for most stable PE. Verify the indication, renal and hepatic function, interactions and bleeding risk.
| Treatment | Typical adult VTE regimen when suitable |
|---|---|
| Apixaban | 10 mg twice daily for seven days, then 5 mg twice daily |
| Rivaroxaban | 15 mg twice daily for 21 days, then 20 mg once daily. Take both strengths with food. |
| Dabigatran or edoxaban | Start the oral drug after at least five days of therapeutic parenteral anticoagulation. Check the individual label for the oral dose. |
- Pregnancy-associated VTE: Therapeutic weight-adjusted LMWH is first line when stable, using a specialist-directed once- or twice-daily regimen. Treat through the remainder of pregnancy and until six weeks postpartum, with a total course of at least three months. Seek specialist advice on the peripartum plan and postpartum drug choice, including breastfeeding.
- Renal impairment: Use creatinine clearance and the individual SmPC. The drugs have different thresholds. UFH is useful in severe impairment or where rapid reversal is important. Specialist advice may be needed on adjusted LMWH or longer-term treatment.
- Triple-positive antiphospholipid syndrome: Prefer a vitamin K antagonist after specialist assessment.
- Active cancer: Consider tumour location, current and potential bleeding, platelet count, renal function, drug interactions, absorption, planned procedures and the patient’s preferences. A DOAC is suitable for some patients. ESMO prefers LMWH for VTE in luminal gastrointestinal cancer. ITAC also favours considering oral agents when gastrointestinal or genitourinary bleeding risk is low, absorption is reliable and important interactions are absent. Discuss the plan with oncology or haematology. Active major bleeding changes whether anticoagulation can be given at all. Treat for at least six months when suitable under ITAC, then reassess based on cancer activity, bleeding risk and preferences.
ESMO cancer-associated VTE guideline · ITAC cancer-associated thrombosis guidance.
4. Duration and follow-up
Treat most PE for at least three months. After a first PE associated with a major transient trigger that has resolved, stopping at three months is usually appropriate. If a persistent risk factor remains, or there is no identifiable major reversible trigger, discuss extended therapy based on recurrence risk, bleeding risk and patient preference. Reassess periodically. At follow-up, ask about bleeding, adherence and persistent dyspnoea or reduced exercise tolerance. Persistent symptoms after at least three months of treatment may merit assessment for chronic thromboembolic disease.
HSE Eve protocol · Apixaban EU label · Rivaroxaban EU label · Dabigatran EU label · Edoxaban EU label
Acute Respiratory Distress Syndrome (ARDS)
Acute Respiratory Distress Syndrome (ARDS) is an acute hypoxaemic syndrome with permeability pulmonary oedema resulting from acute, diffuse inflammatory injury to the alveolar-capillary membrane.
Pathophysiological Sequence
- Early exudative phase: Triggered by an initial pulmonary or extrapulmonary insult -> massive release of pro-inflammatory cytokines (IL-1, IL-6, IL-8, TNF-) -> recruitment and activation of neutrophils within the pulmonary microvasculature -> release of reactive oxygen species, proteases, and leukotrienes -> destruction of alveolar capillary endothelial and type I pneumocyte epithelial barriers.
- Alveolar Flooding: Protein-rich fluid, fibrin, and erythrocytes pour into the interstitial space and alveolar lumens, forming dense eosinophilic hyaline membranes lining denuded basement membranes (Diffuse Alveolar Damage [DAD]).
- Surfactant Depletion: Type II pneumocytes are damaged, depleting pulmonary surfactant -> widespread micro-atelectasis -> severe physiological intrapulmonary shunting () where venous blood traverses non-ventilated alveoli -> profound, refractory hypoxaemia resistant to supplemental oxygen.
- Repair and possible fibrosis: Type II pneumocytes proliferate as the lung repairs. In some patients, organisation and collagen deposition contribute to persistent loss of compliance. The aerated portion of injured lung is small, so a large tidal volume can overdistend it.
Etiological Insults
- Direct Lung Injury: Severe pneumonia (bacterial, viral [e.g., influenza, COVID-19], fungal), aspiration of acidic gastric contents (Mendelson's syndrome), pulmonary contusion, inhalation of toxic gases/smoke, near-drowning.
- Indirect Lung Injury: Sepsis and septic shock (the most common indirect cause), severe acute pancreatitis, massive trauma with haemorrhagic shock, transfusion-related acute lung injury (TRALI), which can follow a single component, severe burns, drug overdose.
New hypoxaemia and bilateral oedema during or within six hours of transfusion warrant immediate evaluation for TRALI and other transfusion reactions. Stop the transfusion and notify the transfusion service. Circulatory overload can have a similar radiographic appearance. Review the preceding respiratory course, fluid balance and evidence of hydrostatic oedema.
Berlin definition and newer global criteria
The 2012 Berlin definition requires acute onset within a week of a known insult or new or worsening respiratory symptoms, bilateral opacities inadequately explained by effusion, collapse or nodules, and respiratory failure inadequately explained by heart failure or fluid overload. If there is no obvious ARDS risk factor, obtain objective assessment for a hydrostatic cause. A normal ejection fraction alone cannot exclude elevated left-sided filling pressures.
| Berlin severity | Pressure criterion | |
|---|---|---|
| Mild | >200 to ≤300 mmHg | PEEP or CPAP ≥5 cmH₂O |
| Moderate | >100 to ≤200 mmHg | PEEP ≥5 cmH₂O |
| Severe | ≤100 mmHg | PEEP ≥5 cmH₂O |
Worked example. At 10.0 kPa, multiply by 7.5 to obtain 75 mmHg. On 1.0 the ratio is 75 mmHg. At PEEP 8 cmH₂O, this is severe under Berlin if the other criteria are met.
The new global definition adds a nonintubated group on high-flow nasal oxygen at ≥30 L/min or NIV/CPAP with end-expiratory pressure ≥5 cmH₂O. The oxygenation criterion is ≤300 mmHg or ≤315 when saturation is ≤97%. It accepts bilateral findings on lung ultrasound performed by a trained operator and has a separate resource-limited category. Use the named definition when interpreting a case.
Lung-protective and supportive management
- Ventilation: Start near 6 mL/kg predicted body weight based on height and sex, within a lung-protective range of about 4–8 mL/kg. Limit plateau pressure to about 30 cmH₂O or less. Titrate PEEP and oxygen to gas exchange and haemodynamic response. Higher PEEP can be appropriate in moderate to severe disease. A rise in CO₂ can be accepted if the clinical situation permits.
- Prone position: ESICM recommends early proning for invasively ventilated ARDS with persistent <150 mmHg after optimisation, for at least 16 consecutive hours per session. PROSEVA reported 28-day mortality of 16.0% with prone sessions versus 32.8% supine in the population studied.
- Neuromuscular blockade: ESICM advises against routine continuous infusion in moderate to severe ARDS unrelated to COVID-19. ATS conditionally supports use in selected early severe ARDS, for example when serious dyssynchrony persists despite ventilator and sedation adjustments. Reassess the ongoing need.
- Fluid management: Once shock has resolved, review fluid balance. A conservative strategy can improve ventilator-free days. Treat the underlying cause and involve an experienced critical-care team for severe hypoxaemia despite optimisation.
Berlin definition · Global definition · ESICM support guideline · ATS management update · PROSEVA · FACTT · TRALI consensus
A 45-year-old previously healthy man presents to the emergency department with a 12-hour history of acute right-sided pleuritic chest pain and shortness of breath. He returned 3 days ago from an 8-hour international flight. Physical examination reveals: heart rate 108 bpm, blood pressure 134/82 mmHg, respiratory rate 22 breaths/min, and oxygen saturation 95% on ambient air. Examination of the lower limbs reveals a warm, erythematous right calf with tenderness on palpation along the deep veins measuring 4.5 cm larger in circumference than the left leg. The 12-lead ECG demonstrates sinus tachycardia, and a chest radiograph is normal. Which diagnostic sequence represents the most appropriate next step in clinical management?
Calculate a Wells score of >4.0 points (PE likely); bypass D-dimer testing and arrange an immediate CT Pulmonary Angiography (CTPA).
Calculate a Wells score of 1.5 points (PE unlikely); order a high-sensitivity D-dimer assay and discharge the patient if the level is <500 mcg/L.
Order a quantitative D-dimer assay; if elevated, perform a non-contrast thoracic CT scan to evaluate for aortic dissection.
Perform an immediate Ventilation-Perfusion (V/Q) lung scan as the first-line investigation of choice in all ambulant adult outpatients.
A 62-year-old woman on postoperative day 5 following an elective total hip replacement collapses suddenly while attempting to mobilise. On arrival of the resuscitation team, she is cyanosed, cold, and clammy. Vital signs reveal: blood pressure 72/44 mmHg, heart rate 136 bpm (sinus tachycardia), respiratory rate 34 breaths/min, and oxygen saturation 82% on high-flow oxygen via a reservoir mask. A rapid bedside transthoracic echocardiogram demonstrates severe right ventricular dilatation, McConnell's sign, and flattening of the interventricular septum into the left ventricle. The team considers PE the most likely cause and she remains in shock with a pulse. The hospital can provide surgical and catheter-based reperfusion. Alongside resuscitation, what is the most appropriate next decision?
Rapid intravenous infusion of 2,000 mL of 0.9% normal saline over 20 minutes to restore left ventricular preload.
Oral rivaroxaban 15 mg twice daily taken with a light meal.
Subcutaneous enoxaparin 1.5 mg/kg once daily and transfer to a general surgical ward for continuous observation.
Activate emergency specialist PE assessment for catheter-based mechanical thrombectomy or surgical embolectomy given the recent major operation.
A 54-year-old man admitted to the intensive care unit with severe acute pancreatitis develops sudden respiratory failure on day 3. He is endotracheally intubated and mechanically ventilated. Ventilator settings show a PEEP of 12 cmH2O and an FiO2 of 0.80 (80%). An arterial blood gas reveals: pH 7.28, PaCO2 6.5 kPa (48.8 mmHg), PaO2 9.6 kPa (72 mmHg), and HCO3 22 mmol/L. A portable chest radiograph reveals diffuse, bilateral patchy alveolar opacities throughout all four quadrants. Bedside echocardiography demonstrates a normal left ventricular ejection fraction (65%), normal left atrial dimensions, and no significant valvular disease. The team finds no evidence of fluid overload or elevated left-sided filling pressure. The severe oxygenation deficit persists after initial ventilator optimisation. Which statement correctly categorises his condition under the Berlin definition and outlines the primary mechanical ventilation strategy?
Mild ARDS; manage with high tidal volumes (12 mL/kg actual body weight) and zero positive end-expiratory pressure (ZEEP) to prevent barotrauma.
Cardiogenic pulmonary oedema; initiate a high-dose intravenous furosemide infusion and discontinue positive end-expiratory pressure.
Severe ARDS. Continue lung-protective ventilation near 6 mL/kg predicted body weight, limit plateau pressure to about 30 cmH₂O and start prone positioning for at least 16 consecutive hours.
Moderate ARDS; titrate tidal volumes to 10 mL/kg predicted body weight to eliminate hypercapnia and achieve an arterial pH >7.45.
A haemodynamically stable patient with an unresected gastric cancer has a confirmed proximal DVT. There is no active major bleeding, but the tumour is judged to pose a high risk of mucosal bleeding. Creatinine clearance and platelet count permit full-dose heparin. Which initial treatment is preferred under ESMO guidance?
Use therapeutic LMWH with oncology or haematology input and monitor for bleeding
Give routine systemic fibrinolysis for a stable proximal DVT
Choose an oral factor Xa inhibitor without reviewing the tumour site or interactions
Withhold all treatment for the DVT solely because the patient has cancer
Sections you finish are checked off in the contents.